GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

India accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India ...

Researchers have found in a new research that SGLT2 inhibitors may provide dual benefits in treating both diabetes and fatty ...

This new article publication from Acta Pharmaceutica Sinica B, discusses how melatonin receptor 1a alleviates sleep ...

Guidelines for pregnancy care in individuals with preexisting diabetes mellitus include stopping GLP-1 RA use and avoiding metformin.

The above contradiction raised our curiosity. Do these two common diseases truly affect each other? However, after systematically searching the literature, we found that there was no systemic ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Populations of African descent are at the forefront of the worldwide epidemic of type 2 diabetes mellitus (T2DM). Here, Anne Sumner and colleagues discuss issues related to the diagnosis and ...

Type 2 diabetes (T2DM) is a systematic multi-organ metabolic disease, which is characterized by dynamic interplay among different organs. Pancreatic islet-liver axis is closely associated with normal ...

T2DM: self-reported T2DM and received anti-diabetes medications, or based on clinical test (FBG ≥ 126 mg/dl or HbA1C ≥ 6.5%) Exposure: self-reported tooth loosening (N = 262) ...